Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex: preparation and characterisation. Analytical validation for metal determination by microwave-induced plasma optical emission spectrometry

References

• Altmeyer, C., et al., 2016. Tamoxifen-loaded poly(L-lactide) nanoparticles: development, characterization and in vitro evaluation of cytotoxicity. Materials science & engineering. C, materials for biological applications, 60, 135–142.
   PubMed Web of Science ®Google Scholar
• Alves, S.R., et al., 2020. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells. Journal of inorganic biochemistry, 205, 110984.
   PubMed Web of Science ®Google Scholar
• Andrade, J.M. and Estévez-Pérez, M.G., 2014. Statistical comparison of the slopes of two regression lines: a tutorial. Analytica Chimica acta, 838, 1–12.
   PubMed Web of Science ®Google Scholar
• Antônio, E., et al., 2017. Poly(lactic acid) nanoparticles loaded with ursolic acid: characterization and in vitro evaluation of radical scavenging activity and cytotoxicity. Materials science & engineering. C, materials for biological applications, 71, 156–166.
   PubMed Web of Science ®Google Scholar
• AOAC International, 2012. Official methods of analysis of AOAC International. In: AOAC official methods of analysis, in guidelines for standard method performance requirements (appendix F). Gaithersburg: Association of Official Agricultural Chemists (AOAC) International, 1–17.
   Google Scholar
• Araujo, P., 2009. Key aspects of analytical method validation and linearity evaluation. Journal of chromatography. B, analytical technologies in the biomedical and life sciences, 877 (23), 2224–2234.
   PubMed Web of Science ®Google Scholar
• Balcerzak, M., Swiecicka, E., and Bystronska, D., 1999. Simple Selective spectrophotometric method for the determination of ruthenium in carbon supported Pt-Ru-Ge catalyst. Analytical Letters, 32 (9), 1799–1805.
   Web of Science ®Google Scholar
• Benadiba, M., et al., 2014. Growth inhibitory effects of the diruthenium-ibuprofen compound, [Ru2Cl(Ibp)4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo. Journal of biological inorganic chemistry, 19 (6), 1025–1035.
   PubMed Web of Science ®Google Scholar
• Bettinetti, G., et al., 1991. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyciodextrins in solution. Journal of pharmaceutical sciences, 80 (12), 1162–1170.
   PubMed Web of Science ®Google Scholar
• Blanco, E., Shen, H., and Ferrari, M., 2015. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature biotechnology, 33 (9), 941–951.
   PubMed Web of Science ®Google Scholar
• Choudhury, H., et al., 2019. Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting. International journal of pharmaceutics, 565 (May), 509–522.
   PubMedGoogle Scholar
• Costa, R.D.O., Coutinho, J.P., and Santos, R., 2022. Use of mixture design to optimize nanofabrication of dithiocarbazate–loaded polylactic acid nanoparticles. Journal of applied polymer science, 139 (3), 51504.
   Web of Science ®Google Scholar
• Crucho, C.I.C. and Barros, M.T., 2017. Polymeric nanoparticles: a study on the preparation variables and characterization methods. Materials science and engineering C, 80, 771–784.
   PubMed Web of Science ®Google Scholar
• de Menezes, T.I., et al., 2019. Preparation and characterization of dithiocarbazate Schiff base–loaded poly(lactic acid) nanoparticles and analytical validation for drug quantification. Colloid and polymer science, 297 (11–12), 1465–1475.
   Web of Science ®Google Scholar
• de Oliveira Silva, D., 2010. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer agents in medicinal chemistry, 10 (4), 312–323.
   PubMed Web of Science ®Google Scholar
• de Oliveira Silva, D., 2014. Ruthenium Compounds Targeting Cancer Therapy. In:  Atta-ur-Rahman and M.I. Choudhary, eds. Frontiers in anti-cancer drug discovery. Bentham Science Publishers, 88–156.
   Google Scholar
• Dhaval, M., et al., 2020. Drug nanocrystals: a comprehensive review with current regulatory guidelines. Current drug delivery, 17 (6), 470–482.
   PubMed Web of Science ®Google Scholar
• El Fagui, A. and Amiel, C., 2012. PLA nanoparticles coated with a b-cyclodextrin polymer shell: preparation, characterization and release kinetics of a hydrophobic compound. International Journal of pharmaceutics, 436 (1–2), 644–651.
   PubMed Web of Science ®Google Scholar
• El Fagui, A., et al., 2011. Core-shell nanoparticles containing cyclodextrin in the shell: A. comprehensive study. Polymer, 52 (17), 3752–3761.
   Web of Science ®Google Scholar
• Fernández, K., et al., 2016. Factorial design optimization and characterization of poly-lactic acid (PLA) nanoparticle formation for the delivery of grape extracts. Food chemistry, 207, 75–85.
   PubMed Web of Science ®Google Scholar
• Fischer, B., et al., 2014. Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound K. P1019 and its surfactant-mediated activation. Dalton transactions, 43 (3), 1096–1104.
   PubMed Web of Science ®Google Scholar
• Fujiyoshi, T., et al., 2019. Interpenetrated polymer networks of poly(β-cyclodextrin) and polyvinylpyrrolidone with synergistic and selective sorption capacities. Carbohydrate polymers, 219 (March), 105–112.
   PubMedGoogle Scholar
• Gidwani, B. and Vyas, A., 2014. Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer. Colloids and surfaces. B, biointerfaces, 114, 130–137.
   PubMed Web of Science ®Google Scholar
• Gómez-Galván, F., et al., 2016. Preparation and characterization of soluble branched ionic β-cyclodextrins and their inclusion complexes with triclosan. Carbohydrate polymers, 142, 149–157.
   PubMed Web of Science ®Google Scholar
• Green, J.M., 1996. Peer reviewed: a practical guide to analytical method validation. Analytical Chemistry, 68 (9), 305A–309A.
   Web of Science ®Google Scholar
• Guimarães, D., Cavaco-Paulo, A., and Nogueira, E., 2021. Design of liposomes as drug delivery system for therapeutic applications. International journal of pharmaceutics, 601 (415), 120571.
   PubMedGoogle Scholar
• Hoffman, A.S., 2008. The origins and evolution of “controlled” drug delivery systems. Journal of controlled release, 132 (3), 153–163.
   PubMed Web of Science ®Google Scholar
• Jacob, J., et al., 2018. Biopolymer based nanomaterials in drug delivery systems: a review. Materials Today chemistry, 9, 43–55.
   Web of Science ®Google Scholar
• Jana, P., et al., 2021. Biodegradable polymers in drug delivery and oral vaccination. European Polymer journal, 142, 110155.
   Web of Science ®Google Scholar
• Jansook, P., Ogawa, N., and Loftsson, T., 2018. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. International journal of pharmaceutics, 535 (1–2), 272–284.
   PubMed Web of Science ®Google Scholar
• Jyothi, N.V.N., et al., 2010. Microencapsulation techniques, factors influencing encapsulation efficiency. Journal of microencapsulation, 27 (3), 187–197.
   PubMed Web of Science ®Google Scholar
• Kumari, A., Yadav, S.K., and Yadav, S.C., 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces. B, biointerfaces, 75 (1), 1–18.
   PubMed Web of Science ®Google Scholar
• Lassalle, V. and Ferreira, M.L., 2007. PLA nano- and microparticles for drug delivery: an overview of the methods of preparation. Macromolecular bioscience, 7 (6), 767–783.
   PubMed Web of Science ®Google Scholar
• Layre, A.M., et al., 2005. Nanoencapsulation of a crystalline drug. International journal of pharmaceutics, 298 (2), 323–327.
   PubMed Web of Science ®Google Scholar
• Lee, B.K., Yun, Y., and Park, K., 2016. PLA micro- and nano-particles. Advanced drug delivery reviews, 107, 176–191.
   PubMed Web of Science ®Google Scholar
• Li, H., et al., 2020. Biomedical applications of liquid metal nanoparticles: a critical review. Biosensors, 10 (12), 196.
   PubMedGoogle Scholar
• Linsinger, T.P.J., et al., 2013. Validation of methods for the detection and quantification of engineered nanoparticles in food. Food chemistry, 138 (2–3), 1959–1966.
   PubMed Web of Science ®Google Scholar
• Lizundia, E., et al., 2016. Poly(L-lactide)/branched β-cyclodextrin blends: thermal, morphological and mechanical properties. Carbohydrate polymers, 144, 25–32.
   PubMed Web of Science ®Google Scholar
• Loftsson, T., et al., 1993. Cyclodextrin complexation of NSAIDSs: physicochemical characteristics. European journal of pharmaceutical sciences, 1 (2), 95–101.
   Web of Science ®Google Scholar
• Mandal, P., et al., 2018. Ruthenium(II) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. Dalton transactions, 47 (2), 517–527.
   PubMed Web of Science ®Google Scholar
• McClements, J. and McClements, D.J., 2016. Standardization of nanoparticle characterization: methods for testing properties, stability, and functionality of edible nanoparticles. Critical reviews in food science and nutrition, 56 (8), 1334–1362.
   PubMed Web of Science ®Google Scholar
• Moore, T.L., et al., 2015. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chemical Society reviews, 44 (17), 6287–6305.
   PubMed Web of Science ®Google Scholar
• Mura, P., et al., 2002. Characterization of physicochemical properties of naproxen systems with amorphous b-cyclodextrin-epichlorohydrin polymers. Journal of pharmaceutical and biomedical analysis, 29 (6), 1015–1024.
   PubMed Web of Science ®Google Scholar
• Mura, P., et al., 2005. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. Journal of pharmaceutical and biomedical analysis, 37 (5), 987–994.
   PubMed Web of Science ®Google Scholar
• Ndagi, U., Mhlongo, N., and Soliman, M., 2017. Metal complexes in cancer therapy – an update from drug design perspective. Drug design, development and therapy, 11, 599–616.
   PubMed Web of Science ®Google Scholar
• Pandey, S.K., et al., 2015. Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer. International journal of biological macromolecules, 72, 309–319.
   PubMed Web of Science ®Google Scholar
• Pillin, I., Montrelay, N., and Grohens, Y., 2006. Thermo-mechanical characterization of plasticized PLA: Is the miscibility the only significant factor? Polymer, 47 (13), 4676–4682.
   Web of Science ®Google Scholar
• Poursharifi, M., Wlodarczyk, M.T., and Mieszawska, A.J., 2018. Nano-based systems and biomacromolecules as carriers for metallodrugs in anticancer therapy. Inorganics, 7 (1), 2.
   Web of Science ®Google Scholar
• Pretula, J., Slomkowski, S., and Penczek, S., 2016. Polylactides—methods of synthesis and characterization. Advanced drug delivery reviews, 107, 3–16.
   PubMed Web of Science ®Google Scholar
• Renard, E., et al., 1997a. Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers. European polymer journal, 33 (1), 49–57.
   Web of Science ®Google Scholar
• Renard, E., et al., 1997b. Polycondensation of cyclodextrins with epichlorohydrin. Influence of reaction conditions on the polymer structure. Macromolecular Symposia, 122 (1), 229–234.
   Google Scholar
• Ribani, M., et al., 2004. Validation for chromatographic and electrophoretic methdos. Química Nova, 27 (5), 771–780.
   Web of Science ®Google Scholar
• Ribeiro, G., et al., 2008. Diruthenium(II,III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation. Polyhedron, 27 (3), 1131–1137.
   Web of Science ®Google Scholar
• Riccardi, C., et al., 2019. Anticancer ruthenium(III) complexes and Ru(III)-containing nanoformulations: an update on the mechanism of action and biological activity. Pharmaceuticals, 12 (4), 146.
   Web of Science ®Google Scholar
• Rico, A., et al., 2017. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer–lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale, 9 (30), 10701–10714.
   PubMed Web of Science ®Google Scholar
• Rocha, D.L., et al., 2013. Greening sample preparation in inorganic analysis. TrAC trends in analytical chemistry, 45, 79–92.
   Web of Science ®Google Scholar
• Sahoo, S.K., et al., 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of controlled release, 82 (1), 105–114.
   PubMed Web of Science ®Google Scholar
• Salah, E., et al., 2020. Solid lipid nanoparticles for enhanced oral absorption: a review. Colloids and surfaces. B, biointerfaces, 196 (3), 111305.
   PubMedGoogle Scholar
• Santos, R., et al., 2012. Synthesis and characterization of a diruthenium(II,III)–ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives. Polyhedron, 42 (1), 175–181.
   Web of Science ®Google Scholar
• Scaccia, S. and Goszczynska, B., 2004. Sequential determination of platinum, ruthenium, and molybdenum in carbon-supported Pt, PtRu, and PtMo catalysts by atomic absorption spectrometry. Talanta, 63 (3), 791–796.
   PubMed Web of Science ®Google Scholar
• Schneider, H.-J., et al., 1998. NMR studies of cyclodextrins and cyclodextrin complexes. Chemical reviews, 98 (5), 1755–1786.
   PubMed Web of Science ®Google Scholar
• Seidi, F., Jin, Y., and Xiao, H., 2020. Polycyclodextrins: synthesis, functionalization, and applications. Carbohydrate polymers, 242 (March), 116277.
   PubMedGoogle Scholar
• Shelley, H. and Babu, R.J., 2018. Role of cyclodextrins in nanoparticle-based drug delivery systems. Journal of pharmaceutical sciences, 107 (7), 1741–1753.
   PubMed Web of Science ®Google Scholar
• Sherje, A.P., et al., 2017. Cyclodextrin-based nanosponges: a critical review. Carbohydrate polymers, 173 (1), 37–49.
   PubMedGoogle Scholar
• Sudhindra, P., et al., 2020. Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: a review. Polyhedron, 192, 114827.
   Web of Science ®Google Scholar
• Suoranta, T., Niemelä, M., and Perämäki, P., 2014. Comparison of digestion methods for the determination of ruthenium in catalyst materials. Talanta, 119, 425–429.
   PubMed Web of Science ®Google Scholar
• Szwed, M. and Santos-Oliveira, R., 2016. Nanoparticles with therapeutic properties generate various response of human peripheral blood mononuclear cells. Journal of nanoscience and nanotechnology, 16 (6), 6545–6550.
   PubMed Web of Science ®Google Scholar
• Tabares, J.P.G., et al., 2019. A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands. Inorganica chimica acta, 489 (February), 27–38.
   Google Scholar
• Tadini, M.C., et al., 2017. Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases. Journal of pharmaceutical and biomedical analysis, 145, 576–585.
   PubMed Web of Science ®Google Scholar
• Thauvin, C., et al., 2018. Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles. International journal of pharmaceutics, 548 (2), 771–777.
   PubMed Web of Science ®Google Scholar
• Thompson, M., et al., 1999. Harmonized guidelines for the use of recovery information in analytical measurement. Pure and applied chemistry, 71 (2), 337–348.
   Web of Science ®Google Scholar
• Tsuji, H., 2010. Poly(lactic acid). Bio-based plastics: materials and applications. Hoboken, NJ: John Wiley & Sons, Inc.
   Google Scholar
• Ur-Rehman, H., et al., 2016. Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration. Journal of inorganic biochemistry, 165, 181–191.
   PubMed Web of Science ®Google Scholar
• Ur-Rehman, H., et al., 2020. Self-assembled nanoparticles of diruthenium(II,III)-ibuprofen anticancer metallodrug. Journal of the Brazilian chemical society, 31 (11), 2331–2341.
   Web of Science ®Google Scholar
• Wani, W.A., et al., 2016. Nanostructured materials functionalized with metal complexes: in search of alternatives for administering anticancer metallodrugs. Coordination chemistry reviews, 312, 67–98.
   Web of Science ®Google Scholar
• Wen, M.M., et al., 2017. Nanotechnology-based drug delivery systems for Alzheimer’s disease management: technical, industrial, and clinical challenges. Journal of controlled release, 245, 95–107.
   PubMed Web of Science ®Google Scholar
• Wilcox, R.R., 1997. Comparing the slopes of two independent regression lines when there is complete heteroscedasticity. British journal of mathematical and statistical psychology, 50 (2), 309–317.
   Google Scholar
• Wilson, R.J., et al., 2021. Nanoemulsions for drug delivery. Particuology, 133, 8040.
   Google Scholar
• World Health Organization, 1992. Validation of analytical procedures used in the examination of pharmaceutical materials (Annex 5). WHO Expert Committee on specifications for pharmaceutical preparations (32nd report). Geneva: World Health Organization.
   Google Scholar
• Xu, P., Song, L.X., and Wang, H.M., 2008. Study on thermal decomposition behavior of survived β-cyclodextrin in its inclusion complex of clove oil by nonisothermal thermogravimetry and gas chromatography coupled to time-of-flight mass spectrometry analyses. Thermochimica acta, 469 (1–2), 36–42.
   Web of Science ®Google Scholar
• Zhao, D., et al., 2012. A novel β-cyclodextrin polymer modified by sulfonate groups. Journal of inclusion phenomena and macrocyclic chemistry, 73 (1–4), 93–98.
   Web of Science ®Google Scholar
• Zhu, D., et al., 2016. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta biomaterialia, 30, 144–154.
   PubMed Web of Science ®Google Scholar